CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK109.86m
- SEK93.54m
- SEK17.49m
Brief: CLS Q2 Net Loss Narrows To SEK 13.6 Mln
Brief: CLS To Get SEK 38 Mln Through Rights Issue
Brief: CLS Enters The Italian Market For Focal Laser Ablation
Brief: CLS Receives Additional Order For Prism Products
Brief: ClS Resolves On A Partially Guaranteed Rights Issue Of About SEK 59 Mln
Brief: CLS Gets Second Order From National Institutes Of Health Clinical Center In US
Brief: CLS Signs Agreement With ROSE Urology
Brief: CLS Appoints Håkan Rosqvist As Interim CFO
Brief: Clinical Laserthermia Systems FY Basic EPS SEK -0.12
Brief: Clinical Laserthermia Systems Q4 Operating Loss Widens To SEK 20.41 Mln
Brief: CLS To Get About SEK 23.5 Mln In Connection With Warrant Exercise
Brief: Clinical Laserthermia Systems Files New Patent Application
Brief: Cls Enters Agreement With Supplier IGT
Brief: Cls Gets Market Approval For Tranberg Portfolio In Singapore
Brief: Clinical Laserthermia Systems Gets Order Worth SEK 8.1 Mln
Brief: CLS Selects Quest International To Provide Aftermarket Service, Logistics Operations
Brief: Clinical Laserthermia Q3 Pre-Tax Loss SEK 17.2 Mln
Brief: Clinical Laserthermia Systems 9M Basic EPS at SEK -0.12
Brief: CLS Enters Urology Market In Portugal In Collaboration With Avanco Advanced Medical Solutions